analiza aiqbench
Imperagen's £5 million seed round validates a closed-loop platform that combines quantum physics simulations with specialized AI models to achieve over 500-fold improvements in enzyme performance. This approach addresses the inefficiencies of traditional manual screening by using automated robotics to physically test mutations identified through in silico quantum calculations. The technology offers a scalable solution for accelerating biocatalysis in pharmaceutical manufacturing and sustainable chemical production.
£5 Million Fuels Imperagen’s Quantum-AI Enzyme Engineering
£5 million fuels Imperagen’s enzyme engineering, deploying quantum physics & AI modeling.
Imperagen, a University of Manchester spin-out, has secured £5 million to advance its enzyme engineering platform powered by a combination of quantum physics, artificial intelligence, and laboratory automation. The seed funding round, led by PXN Ventures, brings the company’s total investment to £8.5 million and will fund expansion of its research and development efforts over the next 18 months. Imperagen’s closed-loop system has already demonstrated substantial gains, achieving over 500 times improvements in enzyme performance in a project…
Extras afișat conform termenilor RSS ai publicației · 78 cuvinte · textul integral și figurile sunt pe site-ul publicației
